Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques
Payal P. PratapiD, Christopher A. CottrelliD, James Quinn, Diane G. CarnathaniD, Daniel L. V. Bader, Andy S. TraniD, Chiamaka A. Enemuo, Julia T. NgoiD, Sara T. RicheyiD, Hongmei GaoiD, Xiaoying SheniD, Kelli GreeneiD, Jonathan HurtadoiD, Katarzyna Kaczmarek MichaelsiD, Elana Ben‐AkivaiD, Ashley A. LemniosiD, Mariane B. MeloiD, Joel D. AlleniD, Gabriel OzorowskiiD, Max CrispiniD, Bryan S. BrineyiD, David C. MontefioriiD, Guido SilvestriiD, Darrell J. IrvineiD, Shane CrottyiD, Andrew B. WardiD
Abstract
SummaryDuring infection, the fusion peptide (FP) of HIV envelope glycoprotein (Env) serves a central role in viral fusion with the host cell. As such, the FP is highly conserved and therefore an attractive epitope for vaccine design. Here, we describe a vaccination study in non-human primates (NHPs) where glycan deletions were made on soluble HIV Env to increase FP epitope exposure. When delivered via implantable osmotic pumps, this immunogen primed immune responses against the FP, which were then boosted with heterologous trimers resulting in a focused immune response targeting the conserved FP epitope. Although autologous immunizations did not elicit high affinity FP-targeting antibodies, the conserved FP epitope on a heterologous trimer further matured the lower affinity, FP-targeting B cells. This study suggests using epitope conservation strategies on distinct Env trimer immunogens can focus humoral responses on desired neutralizing epitopes and suppress immune-distracting antibody responses against non-neutralizing epitopes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 1.37
- Field percentile
- top 21%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
C. A. Cottrell, J. van Schooten, … M. J. van Gils·bioRxiv·Feb 5, 2020
- Focusing antibody responses to the fusion peptide in rhesusmacaques
C. A. Cottrell, P. P. Pratap, … A. B. Ward·bioRxiv·Jun 26, 2023
- Virus-Like Particle Based-Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
A. T. Mogus, L. Liu, … B. Chackerian·bioRxiv·Sep 25, 2020
- Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles
Seo-Ho Oh, Dedeepya R. Gudipati, … Rui Kong·npj VaccinesPeer-reviewed·Nov 14, 2025
- Mapping polyclonal antibody responses in non-human primates vaccinated with HIV Env trimer subunit vaccines
B. Nogal, M. Bianchi, … A. B. Ward·bioRxiv·Nov 7, 2019
- Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope
M. E. Abernathy, H. B. Gristick, … P. J. Bjorkman·bioRxiv·Mar 17, 2021